Drugs / TMV vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06324240 | Dec 2025 → Dec 2026 expected | female breast carcinoma, triple-negative breast carcinoma | Emory University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TMV vaccine | “Given TMV vaccine ID” NCT06324240 ↗ |
| Modality | Vaccine | “personalized vaccine (tumor membrane vesicle or TMV vaccine)” NCT06324240 ↗ |